PL356096A1 - Kompleks N-formylopeptydowego receptora z czynnikiem modyfikacji ścieżki sygnału kinazy białkowej Goraz sposoby zmiany przekazywania sygnału poprzezstymulację czynnikami prozapalnymi - Google Patents

Kompleks N-formylopeptydowego receptora z czynnikiem modyfikacji ścieżki sygnału kinazy białkowej Goraz sposoby zmiany przekazywania sygnału poprzezstymulację czynnikami prozapalnymi

Info

Publication number
PL356096A1
PL356096A1 PL00356096A PL35609600A PL356096A1 PL 356096 A1 PL356096 A1 PL 356096A1 PL 00356096 A PL00356096 A PL 00356096A PL 35609600 A PL35609600 A PL 35609600A PL 356096 A1 PL356096 A1 PL 356096A1
Authority
PL
Poland
Prior art keywords
protein kinase
receptor complex
modification agent
signal pathway
peptide receptor
Prior art date
Application number
PL00356096A
Other languages
English (en)
Inventor
James A. Clagett
Craig Palmer
Original Assignee
Histatek, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek, Llc filed Critical Histatek, Llc
Publication of PL356096A1 publication Critical patent/PL356096A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL00356096A 1999-10-15 2000-10-12 Kompleks N-formylopeptydowego receptora z czynnikiem modyfikacji ścieżki sygnału kinazy białkowej Goraz sposoby zmiany przekazywania sygnału poprzezstymulację czynnikami prozapalnymi PL356096A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15967799P 1999-10-15 1999-10-15
PCT/US2000/028183 WO2001029069A1 (en) 1999-10-15 2000-10-12 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent

Publications (1)

Publication Number Publication Date
PL356096A1 true PL356096A1 (pl) 2004-06-14

Family

ID=22573520

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356096A PL356096A1 (pl) 1999-10-15 2000-10-12 Kompleks N-formylopeptydowego receptora z czynnikiem modyfikacji ścieżki sygnału kinazy białkowej Goraz sposoby zmiany przekazywania sygnału poprzezstymulację czynnikami prozapalnymi

Country Status (16)

Country Link
EP (1) EP1222199A4 (pl)
JP (1) JP2004507441A (pl)
KR (1) KR20020057972A (pl)
CN (1) CN100497374C (pl)
AU (1) AU8014200A (pl)
BR (1) BR0014742A (pl)
CA (1) CA2387559A1 (pl)
CZ (1) CZ20021342A3 (pl)
EA (1) EA200200451A1 (pl)
HU (1) HUP0203688A2 (pl)
IL (1) IL149125A0 (pl)
MX (1) MXPA02003782A (pl)
NO (1) NO20021732L (pl)
PL (1) PL356096A1 (pl)
WO (1) WO2001029069A1 (pl)
ZA (1) ZA200202937B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
WO2004100978A1 (en) * 2003-05-13 2004-11-25 Medvet Science Pty. Ltd. A method of modulating cellular transmigration and agents for use therein
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
WO2011036308A1 (en) * 2009-09-28 2011-03-31 Theramab Gmbh Method for preclinical testing of immunomodulatory drugs
CN115466306B (zh) * 2022-01-25 2025-06-27 香港中文大学（深圳） 一种靶向细胞膜表面甲酰肽受体的多肽、药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9815288A (pt) * 1997-11-13 2001-02-13 Histatek Llc Composição farmacêutica, processos para inibir a desgranulação de mastócitos, para tratar asma em um paciente, para tratar inflamação em um paciente, para inibir a liberação de citocinas em um paciente, para inibir a liberação de histaminas em um paciente, para inibir a liberação de leucotrienos em um paciente, para reduzir a adesão, migração e agregação de linfócitos, eosinófilos e neutrófilos para um sìtio de inflamação em um paciente, para reduzir a produção de anticorpos ige no sìtio de inflamação em um paciente, para inibir a permeabilidade vascular aumentada no sìtio de inflamação em um paciente, e, para tratar inflamação crÈnica em um paciente.

Also Published As

Publication number Publication date
CN1633447A (zh) 2005-06-29
MXPA02003782A (es) 2002-12-13
BR0014742A (pt) 2002-08-27
CZ20021342A3 (cs) 2003-01-15
ZA200202937B (en) 2003-09-23
EA200200451A1 (ru) 2002-10-31
JP2004507441A (ja) 2004-03-11
CN100497374C (zh) 2009-06-10
KR20020057972A (ko) 2002-07-12
CA2387559A1 (en) 2001-04-26
AU8014200A (en) 2001-04-30
NO20021732L (no) 2002-06-12
EP1222199A4 (en) 2003-03-12
WO2001029069A1 (en) 2001-04-26
IL149125A0 (en) 2002-11-10
HUP0203688A2 (hu) 2003-02-28
NO20021732D0 (no) 2002-04-12
EP1222199A1 (en) 2002-07-17

Similar Documents

Publication Publication Date Title
IL149125A0 (en) N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent
IL136742A0 (en) Kappa receptor opioid peptides
PL348375A1 (en) Pyrrolidine derivatives-ccr-3 receptor antagonists
EP1104440A4 (en) A G-PROTEIN-COUPLED 7 TRANSMEMBRANE RECEPTOR
AU1956701A (en) G-protein coupled receptors
SG80041A1 (en) Muscarinic receptor antagonists
EP1157038A4 (en) CLONING OF A P2Y-LIKE 7TM RECEPTOR (AXOR17)
IL148515A0 (en) Human g-protein coupled receptor
IL148043A0 (en) Novel integrin receptor antagonists
EP1185265A4 (en) IL-8 RECEPTOR ANTAGONISTS
IL196053A0 (en) Novel human g-protein coupled receptor
EP1180028A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP1054903A4 (en) FISHBOY, A G PROTEIN COUPLED RECEPTOR
AU4511901A (en) Nonpeptide kappa opioid receptor antagonists
AU5344799A (en) Kappa (op2) opioid receptor antagonists
EP1171467A4 (en) AXOR-27, A RECEPTOR COUPLED TO A G-PROTEIN
EP1071766A4 (en) HUMAN PROTEIN G COUPLED TO GPR6sb RECEPTOR
EP1129101A4 (en) G-PROTEIN COUPLED TO THE 7TM RECEPTOR
AU5572500A (en) Vegf receptor antagonists
AU5748300A (en) Il-8 receptor antagonists
AU5168900A (en) Il-8 receptor antagonists
PL357650A1 (pl) Antagoniści niepeptydowych receptorów tachykininowych
EP1155031A4 (en) G PROTEIN TORQUE RECEPTOR, SAID AXOR-14
AU5875200A (en) Heterodimeric opioid g-protein coupled receptors
AU5622400A (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)